Apollomics (APLM) Accumulated Expenses (2022 - 2025)

Apollomics (APLM) posted quarterly Accumulated Expenses of $6.1 million for Q4 2025, down 14.64% year-on-year from $7.2 million in Q4 2024, and down 40.43% on a QoQ basis from $10.3 million in Q2 2025.

Apollomics (APLM) Accumulated Expenses (2022 - 2025) Analysis & Trends

Apollomics (APLM) has reported Accumulated Expenses for 4 consecutive years, with $6.1 million the latest figure, recorded in Q4 2025.

  • Quarterly Accumulated Expenses fell 14.64% year-over-year to $6.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.1 million (down 14.64% YoY) and the FY2025 annual result came in at $6.1 million, down 14.64% from the prior year.
  • Accumulated Expenses declined to $6.1 million in Q4 2025 per APLM's latest filing, from $10.3 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for APLM reached as high as $12.8 million in Q2 2023 and fell as low as $6.1 million in Q4 2025.
  • A 4-year average of $9.4 million and a median of $9.2 million in 2023 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2024 — Accumulated Expenses tumbled 30.67% — and 2025, when it increased 15.68%.
  • Year by year, Accumulated Expenses stood at $11.7 million in 2022, then slipped by 21.52% to $9.2 million in 2023, then slipped by 21.79% to $7.2 million in 2024, then retreated by 14.64% to $6.1 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $6.1 million, $10.3 million, and $7.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Apollomics 2.66 Bn 2.66 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 6.12 Mn
Jun 30, 2025 10.27 Mn
Dec 31, 2024 7.17 Mn
Jun 30, 2024 8.88 Mn
Dec 31, 2023 9.16 Mn
Jun 30, 2023 12.80 Mn
Dec 31, 2022 11.68 Mn